JAMA Clinical Reviews

JAMA Network
  • 4.7 (26)
  • MEDICINE
  • UPDATED WEEKLY

Author interviews that explore the latest clinical reviews.

  1. Obesity-Related Cancer

    2 DAYS AGO

    Obesity-Related Cancer

    Overweight and obesity may cause 10% of new cancer diagnoses annually in the US. In this JAMA Review in the Translational Science series, author Neil Iyengar, MD, of Emory University discusses the biological pathways that may promote cancer in people with overweight or obesity and potential therapies with JAMA Deputy Editor Mary McDermott, MD. Related Content: Obesity and Cancer

    21 min
  2. Diagnosis and Treatment of Chronic, Noninfectious Diarrhea

    2 MAR

    Diagnosis and Treatment of Chronic, Noninfectious Diarrhea

    Chronic noninfectious diarrhea affects approximately 6% to 7% of adults in the US and significantly impairs quality of life. Author William Chey, MD, of the University of Michigan joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss strategies for diagnosis and treatment of chronic, noninfectious diarrhea. Related Content: Chronic, Noninfectious Diarrhea

    20 min
  3. Does This Patient Have Volume Overload? The Rational Clinical Examination

    23 FEB

    Does This Patient Have Volume Overload? The Rational Clinical Examination

    Accurate assessment of intravascular volume facilitates decisions about fluid management in patients with volume overload. Author Edmund A. Liles Jr, MD, of the University of Utah joins JAMA Associate Editor David Simel, MD, MHS, to discuss best evidence from physical exam findings including ultrasound, radiographs, and lab studies for determining volume overload in spontaneously breathing patients. Related Content: Does This Patient Have Volume Overload?

    19 min
  4. Type 1 Diabetes: Diagnosis and Management

    16 FEB

    Type 1 Diabetes: Diagnosis and Management

    Type 1 diabetes affects approximately 2 million people in the US and 8.4 million people worldwide. Author Desmond Schatz, MD, of the University of Florida joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of type 1 diabetes. Related Content: Type 1 Diabetes

    17 min
  5. Pharmaceutical Pricing: JAMA Talks With Mark Cuban

    12 FEB

    Pharmaceutical Pricing: JAMA Talks With Mark Cuban

    Mark Cuban, entrepreneur, investor, and cofounder of the Mark Cuban Cost Plus Drug Company, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the role of pharmacy benefit managers, insurance formularies, and opaque pricing practices that shape how most Americans access prescription drugs. Hear why he thinks doctors are the good guys in a broken system. Related Content: Pharmaceutical Pricing—JAMA Talks With Mark Cuban

    33 min
  6. Medications for Opioid Use Disorder, Withdrawal, and Overdose

    11 FEB

    Medications for Opioid Use Disorder, Withdrawal, and Overdose

    Opioid use disorder is the third most prevalent substance use disorder worldwide. Author Alexander Walley, MB, MSc, of Boston Medical Center and Boston University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the efficacy, safety, and practical considerations of treating patients with medications for opioid use disorder, opioid withdrawal, and opioid overdose. Related Content: Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose

    24 min
  7. Ovarian Cancer Prevention With Opportunistic Fallopian Tube Removal

    2 FEB

    Ovarian Cancer Prevention With Opportunistic Fallopian Tube Removal

    Ovarian cancer may be prevented with removal of the fallopian tubes during pelvic or select abdominal surgery in eligible women. This procedure, opportunistic salpingectomy, can be offered to more eligible women. Author Jurgen M. Piek, MD, PhD, of the Catharina Cancer Institute discusses this and more with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content: Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma

    18 min
  8. IgA Nephropathy in Adults

    26 JAN

    IgA Nephropathy in Adults

    IgA nephropathy is a chronic kidney disease involving deposition of IgA-containing immune complexes in the glomerulus, which often causes kidney failure within 10 to 20 years. Author Michelle Marie O'Shaughnessy, MB, BCh, BAO, MS, of Galway University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the symptoms, risk factors, diagnosis, treatment, and prognosis of IgA nephropathy in adults. Related Content: IgA Nephropathy in Adults

    27 min
See All (473)

Hosts & Guests

Ratings & Reviews

4.7
out of 5
26 Ratings

About

Author interviews that explore the latest clinical reviews.

Information

  • Channel
    JAMA Network
  • Creator
    JAMA Network
  • Years Active
    2015 - 2026
  • Episodes
    473
  • Rating
    Clean
  • Copyright
    © 2025 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies.
  • Show Website
    JAMA Clinical Reviews

More From JAMA Network

You Might Also Like